Following U.S. Stocks may claim a “BIG Change,” in the course of current trading session: Johnson & Johnson (NYSE:JNJ), GlaxoSmithKline (NYSE:GSK), Intercept Pharmaceuticals (NASDAQ:ICPT), CONN’S, (NASDAQ:CONN)
- Johnson & Johnson (NYSE:JNJ), with shares dwindled -0.49% is now trading at $100.99. The Stock is active as 538,997.00 shares changed hands versus its average volume of 8.30M shares.
- GlaxoSmithKline plc (ADR) (NYSE:GSK), with shares dipped -2.33% is now trading at $46.11. The Stock is active as 497,584.00 shares changed hands versus its average volume of 3.27M shares.
- Intercept Pharmaceuticals Inc (NASDAQ:ICPT) with shares dropped -2.84% is now trading at $286.75. The Stock is active as 381,679.00 shares changed hands versus its average volume of 663,036.00 shares.
- CONN’S, Inc (NASDAQ:CONN) with shares incline 0.66% is now trading at $28.84. The Stock is active as 618,630.00 shares changed hands versus its average volume of 775,111.00 shares.
Latest NEWS regarding these Stocks are depicted underneath:
Johnson & Johnson (NYSE:JNJ) and GlaxoSmithKline plc (ADR) (NYSE:GSK)
According to CNBC, Johnson & Johnson, GlaxoSmithKline – The two companies settled a lawsuit over allergy ads. J&J’s McNeil unit had accused Glaxo of making unsupported claims about advantages of its Flonase product over J&J’s Benadryl and Zyrtec.
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices & GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, including vaccines, over-the-counter medicines, and health-related consumer products worldwide.
Intercept Pharmaceuticals Inc (NASDAQ:ICPT)
Intercept Pharmaceuticals, Inc. (ICPT) today disclosed the pricing of an underwritten public offering of 1,200,000 shares of its common stock. The underwriters intend to offer the shares of common stock from time to time for sale in one or more transactions on The Nasdaq Global Select Market, in the over-the-counter market, through negotiated transactions or otherwise at market prices prevailing at the time of sale, at prices related to prevailing market prices or at negotiated prices. Intercept granted the underwriters 30-day option to purchase up to an additional 180,000 shares of common stock, on the same terms and conditions.
All shares in the offering are being sold by Intercept, with estimated total gross proceeds to Intercept (before deducting underwriters’ discounts and commissions and estimated offering expenses) of almost $338.4 million (or approximately $389.2 million if the underwriters exercise in full their option to purchase additional shares). The offering is expected to close on or about April 6, 2015, subject to customary closing conditions.
Intercept Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics to treat chronic liver and intestinal diseases utilizing its proprietary bile acid chemistry.
CONN’S, Inc. (NASDAQ:CONN)
CONN’S, Inc. (CONN) today promulgated its financial results for the fourth quarter and fiscal year ended January 31, 2015.
Consolidated revenues raised 18.2% to $426.7 million due to new store openings and an raise in same store sales of 1.3%;
Retail gross margin declined 110 basis points to 39.5%;
Adjusted retail segment operating revenue reduced 7.0% to $45.7 million;
Credit segment operating loss raised $9.5 million to an operating loss of $11.3 million, driven by increased provision for bad debts;
The percentage of the customer portfolio balance 60+ days delinquent was 9.7% as of January 31, 2015 compared to 8.8% as of January 31, 2014, with a sequential decrease of 30 basis points from October 31, 2014; and
Diluted earnings were $0.42 for each share compared to diluted earnings of $0.75 for each share.
Conn’s, Inc. works as a specialty retailer of durable consumer goods and related services in Texas, Arizona, Louisiana, Oklahoma, and New Mexico, the United States. The company’s stores provide home appliances, including refrigerators, freezers, washers, dryers, dishwashers, and ranges; furniture and mattresses comprising furniture and related accessories for the living room, dining room, and bedroom, in addition to traditional and specialty mattresses; and home office products consisting of computers, tablets, printers, and accessories.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
